Anti-malaria drugs could be a potential treatment for Parkinson’s disease
17 July 2015 | By Victoria White
Scientists have found that existing anti-malaria drugs, Chloroquine and Amodiaquine, could be a potential treatment for Parkinson's disease...
List view / Grid view
News
Novogen’s Anisina receives Orphan Drug Designation from FDA for neuroblastoma
16 July 2015 | By Victoria White
Novogen has received notification FDA that its chemotherapy candidate drug, Anisina, has been granted Orphan Drug Designation for neuroblastoma...
Achaogen awarded $4.5 million contract to advance LpxC inhibitors
16 July 2015 | By Victoria White
Achaogen has been awarded a $4.5 million contract for the discovery and development of LpxC inhibitors for the treatment of bacterial infections...
Two Stat3 inhibitors show potential in fighting brain and breast cancers
16 July 2015 | By Victoria White
Researchers have discovered two chemical compounds that effectively stop the growth of brain cancer cells and breast tumours by inhibiting the Stat3 protein...
New resource makes CRISPR/Cas9 technology even more user friendly
16 July 2015 | By Victoria White
Researchers have developed a user-friendly resource to accompany the powerful CRISPR/Cas9 tool, which has been widely adopted to make precise changes in DNA...
Galapagos licenses HUB Organoid Technology for use in cystic fibrosis and IBD research
15 July 2015 | By Victoria White
Galapagos has entered into a licensing agreement with the HUB foundation for use of Organoid Technology for preclinical research in cystic fibrosis and IBD...
MUSC and Bristol-Myers Squibb announce research collaboration focused on fibrotic diseases
15 July 2015 | By Victoria White
MUSC and Bristol-Myers Squibb have entered into a research collaboration focused on fibrotic diseases, including scleroderma and renal fibrosis...
Gene therapy gives long-term protection to photoreceptor cells in retinitis pigmentosa model
15 July 2015 | By Victoria White
Scientists have shown that gene therapy can give protection to the light-sensitive photoreceptor cells responsible for colour vision in retinitis pigmentosa...
MRC, GSK and five leading UK universities collaborate to crack difficult disease areas
15 July 2015 | By Victoria White
GSK and MRC are to collaborate on a unique open innovation research initiative aiming to improve scientists’ understanding of inflammatory diseases...
Stem cells might heal damaged lungs
15 July 2015 | By Victoria White
Weizmann Institute scientists have shown how it might be possible to use embryonic stem cells to repair damaged lung tissue...
The Francis Crick Institute and GSK join forces to forge new scientific discoveries
14 July 2015 | By Victoria White
The Francis Crick Institute and GSK are to partner up to explore new avenues of medical research and drug discovery across a broad range of diseases...
Preclinical studies suggest Anisina may improve chemotherapy effectiveness in childhood cancer
14 July 2015 | By Victoria White
A proof of concept study demonstrates Anisina has the potential to improve the effectiveness of chemotherapy in children and reduce life-long side-effects...
Imperial Innovations gets GBP 50 million EIB backing to strengthen investment in biotech spin-offs
14 July 2015 | By Victoria White
Imperial Innovations Group has secured a new GBP 50 million loan from the EIB to support investment in the UK biotech and life science sector...
Researchers identify a gene linked to neurodegenerative disorders – SLC25A46
14 July 2015 | By Victoria White
Researchers have discovered and characterised a previously unknown disease gene, SLC25A46, linked to the degeneration of optic and peripheral nerve fibres...
CiMaas and Pharmacell announce collaboration
13 July 2015 | By Victoria White
CiMaas and PharmaCell have announced a collaboration where PharmaCell will provide consulting services on GMP-compliance to CiMaas...